Evidence map›Paper›PMID 24373844›Full record

ArticleProtein expression and purification2014

GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells.

Wen Wei, Ji Min Kim, Danny Medina, Edward G Lakatta, Li Lin

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wen WeiLaboratory of Cardiovascular Sciences, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore, MD 21224, United States.
Ji Min KimLaboratory of Cardiovascular Sciences, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore, MD 21224, United States.
Danny MedinaGeneArt Division, Life Technologies-Invitrogen Inc., 5823 Newton Drive, Carlsbad, CA 92008, United States.
Edward G LakattaLaboratory of Cardiovascular Sciences, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore, MD 21224, United States.
Li LinLaboratory of Cardiovascular Sciences, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore, MD 21224, United States. Electronic address: linli@mail.nih.gov.
National Institute on Aging · US

Funding

Soluble Receptor for Advanced Glycation End Products for Therapeutic ApplicationZIAAG000875 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 2009 to 2016
$1.9M
Intramural NIH HHS ZIA AG000875
6 · The paper itself

Abstract

Soluble receptor for advanced glycation end products (sRAGE) is a secreted mammalian protein that functions as a decoy to counter-react RAGE signaling-resultant pathological conditions, and has high therapeutic potentials. Our prior studies showed that recombinant human sRAGE expressed in Chinese hamster, Ceanothus griseus, ovary (CHO) cells is modified by specific N-glycosylation, and exhibits higher bioactivity than that expressed in other host systems including insect Spodoptera frugiperda cells. Here, we show that GeneOptimizer software program-assisted, reengineered sRAGE cDNA enhances the recombinant protein expression in CHO cells. The cDNA sequence encoding human sRAGE was optimized for RNA structure, stability, and codon usages in CHO cells. We found that such optimization augmented sRAGE expression over 2 folds of its wild-type counterpart. We also studied how individual parameter impacted sRAGE autologous expression in CHO cells, and whether sRAGE bioactivity was compromised. We found that the enhanced expression appeared not to affect sRAGE N-glycosylation and bioactivity. Optimization of sRAGE expression provides a basis for future large-scale production of this protein to meet medical needs.

Indexed as

AnimalsCHO CellsCricetinaeCricetulusDNA, ComplementaryHEK293 CellsHumansProtein EngineeringReceptor for Advanced Glycation End ProductsReceptors, ImmunologicRecombinant ProteinsDNA, ComplementaryReceptor for Advanced Glycation End ProductsReceptors, ImmunologicRecombinant ProteinsCHOGeneOptimizer programProtein expressionsRAGE

Identifiers

PMID24373844
PMCPMC3936886
OpenAlexW2013265865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.